The Safety and Efficacy of Epidural Oxycodone
NCT02573909 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2023-03-16
Summary
There are conflicting results in earlier studies concerning the safety and efficacy of epidural oxycodone. In a study by Bäcklund and colleagues, epidural oxycodone was as effective as intravenous oxycodone, so they did not recommend epidural use of oxycodone. In another study, Yanagidate and Dohi reported that oxycodone was as effective in pain treatment with double dose compared to epidural morphine. In our previous study, epidural oxycodone provided safe and effective pain relief when compared to intravenous oxycodone.
In the present study, the aim was to compare the efficacy and safety of epidural or intravenous oxycodone in patients undergoing elective gynecological surgery with planned epidural pain treatment.
Conditions
- Pain, Postoperative
Interventions
- DRUG
-
Oxycodone intravenously
Oxycodone intravenously 0,1mg/kg
- DRUG
-
Oxycodone epidurally
Oxycodone 0,1 mg epidurally
Sponsors & Collaborators
-
Admescope Ltd
collaborator INDUSTRY -
Kuopio University Hospital
lead OTHER
Principal Investigators
-
Merja Kokki, PhD · Kuopio University Hospital, Kuopio, Finland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-01
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- Finland
Study Locations
More Related Trials
-
A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
NCT01427283 ·Status: COMPLETED ·Phase: PHASE3
-
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01167699 ·Status: COMPLETED ·Phase: PHASE3
-
Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
NCT01427270 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
NCT01358526 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
NCT02165930 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.
NCT03389750 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
NCT04948307 ·Status: COMPLETED ·Phase: NA
-
Depot Naltrexone Treatment of Opioid Dependent Parolees
NCT00756990 ·Status: COMPLETED ·Phase: NA
-
Increasing Naloxone Access for Persons Who Use Opioids
NCT04303000 ·Status: COMPLETED ·Phase: PHASE4
-
Aprepitant Effects on Oxycodone Response
NCT00999544 ·Status: COMPLETED ·Phase: NA
-
Pharmacodynamics and Arteriovenous Differences of Naloxone in Healthy Participants Exposed to an Opioid
NCT02405988 ·Status: COMPLETED ·Phase: NA
-
Methadone and Ketamine for Neuropathic Pain Treatment
NCT02233452 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
NCT04091009 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Evaluate Unintended Prolonged Opioid Use
NCT04024397 ·Status: COMPLETED
-
Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain
NCT00490919 ·Status: COMPLETED ·Phase: PHASE3
-
Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence
NCT02052258 ·Status: UNKNOWN ·Phase: PHASE1
-
Blood Naloxone Levels Following Intradermal Injection in Humans
NCT05876572 ·Status: WITHDRAWN ·Phase: PHASE4
-
Reversal of Ketamine Pharmacodynamic Effects With Naloxone
NCT00921765 ·Status: TERMINATED ·Phase: PHASE4
-
Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness
NCT00672477 ·Status: COMPLETED ·Phase: PHASE4
-
Naloxone SR Capsules in Patients With Opioid Induced Constipation
NCT00984334 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.
NCT00315874 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
NCT00781898 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants
NCT02745912 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects
NCT00829777 ·Status: COMPLETED ·Phase: PHASE1